Arietis was founded on technologies for discovering antimicrobials developed by Professor Kim Lewis at Northeastern University. Dr. Michael LaFleur oversees daily laboratory operations. Following is a brief description of their backgrounds.
Founder; Professor of Biology and Director, Antimicrobial Discovery Center, Northeastern University
Dr. Lewis is an expert in microbial drug resistance and drug discovery. He received his Ph.D. in Biochemistry from Moscow University and prior to coming to NEU in 2001 has been on the Faculty of MIT, University of Maryland and Tufts University. Dr. Lewis is the author of over 100 publications, several patents and inventions licensed to the Industry
Michael LaFleur, Ph.D.
Chief Operating Officer
Michael LaFleur is a co-inventor on key Arietis technology for synergistically-acting antifungals. Dr. LaFleur received his PhD from Northeastern University, and has worked closely with Dr. Lewis to understand recalcitrant infections, and develop therapeutic approaches to make these infections treatable.